TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.130
-0.200 (-15.04%)
At close: Feb 17, 2026, 4:00 PM EST
1.180
+0.050 (4.42%)
Pre-market: Feb 18, 2026, 7:00 AM EST

TuHURA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22
69173--
Enterprise Value
67178--
Last Close Price
1.134.09--
PB Ratio
3.5111.85--
P/TBV Ratio
23.3012.08--
Debt / Equity Ratio
0.040.01-1.500.01
Net Debt / Equity Ratio
-0.12-0.850.85-1.15
Net Debt / EBITDA Ratio
0.080.710.101.48
Net Debt / FCF Ratio
0.080.840.101.87
Quick Ratio
0.352.501.114.96
Current Ratio
0.403.681.165.13
Return on Equity (ROE)
-418.06%-332.67%-545.67%-
Return on Assets (ROA)
-60.16%-90.68%-86.58%-
Return on Capital Employed (ROCE)
-150.70%-120.60%-1769.90%-80.60%
Earnings Yield
-42.70%-12.54%--
FCF Yield
-36.06%-8.55%--
Buyback Yield / Dilution
42.11%-56.97%--
Updated Nov 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q